84 related articles for article (PubMed ID: 16382040)
1. Studies into the anticancer effects of selenomethionine against human colon cancer.
Nelson MA; Goulet AC; Jacobs ET; Lance P
Ann N Y Acad Sci; 2005 Nov; 1059():26-32. PubMed ID: 16382040
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Meuillet E; Stratton S; Prasad Cherukuri D; Goulet AC; Kagey J; Porterfield B; Nelson MA
J Cell Biochem; 2004 Feb; 91(3):443-58. PubMed ID: 14755676
[TBL] [Abstract][Full Text] [Related]
3. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
[TBL] [Abstract][Full Text] [Related]
4. Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines.
Baines A; Taylor-Parker M; Goulet AC; Renaud C; Gerner EW; Nelson MA
Cancer Biol Ther; 2002; 1(4):370-4. PubMed ID: 12432249
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
6. Selenium and colon cancer--from chemoprevention to new treatment modality.
Rudolf E; Králová V; Cervinka M
Anticancer Agents Med Chem; 2008 Aug; 8(6):598-602. PubMed ID: 18690824
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
8. Curcumin for chemoprevention of colon cancer.
Johnson JJ; Mukhtar H
Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.
Drake EN
Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ERK signaling pathway in cancer therapy.
Kohno M; Pouyssegur J
Ann Med; 2006; 38(3):200-11. PubMed ID: 16720434
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Jariwalla RJ; Gangapurkar B; Nakamura D
Br J Nutr; 2009 Jan; 101(2):182-9. PubMed ID: 18549510
[TBL] [Abstract][Full Text] [Related]
12. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
Fichera A; Little N; Dougherty U; Mustafi R; Cerda S; Li YC; Delgado J; Arora A; Campbell LK; Joseph L; Hart J; Noffsinger A; Bissonnette M
J Surg Res; 2007 Oct; 142(2):239-45. PubMed ID: 17574271
[TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells.
Half E; Sun Y; Sinicrope FA
Cancer Lett; 2007 Jun; 251(2):237-46. PubMed ID: 17189670
[TBL] [Abstract][Full Text] [Related]
14. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
Sinicrope FA
Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of selenium chemoprevention and therapy in prostate cancer.
Nadiminty N; Gao AC
Mol Nutr Food Res; 2008 Nov; 52(11):1247-60. PubMed ID: 18727008
[TBL] [Abstract][Full Text] [Related]
17. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
Arber N
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
[TBL] [Abstract][Full Text] [Related]
19. Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.
Goulet AC; Watts G; Lord JL; Nelson MA
Cancer Biol Ther; 2007 Apr; 6(4):494-503. PubMed ID: 17374985
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
Harris RE
Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
